330 related articles for article (PubMed ID: 34465026)
81. Global analysis of genetic circuitry and adaptive mechanisms enabling resistance to the azole antifungal drugs.
Mount HO; Revie NM; Todd RT; Anstett K; Collins C; Costanzo M; Boone C; Robbins N; Selmecki A; Cowen LE
PLoS Genet; 2018 Apr; 14(4):e1007319. PubMed ID: 29702647
[TBL] [Abstract][Full Text] [Related]
82. RTA2, a novel gene involved in azole resistance in Candida albicans.
Jia XM; Ma ZP; Jia Y; Gao PH; Zhang JD; Wang Y; Xu YG; Wang L; Cao YY; Cao YB; Zhang LX; Jiang YY
Biochem Biophys Res Commun; 2008 Sep; 373(4):631-6. PubMed ID: 18601908
[TBL] [Abstract][Full Text] [Related]
83. Stress-Induced Changes in the Lipid Microenvironment of β-(1,3)-d-Glucan Synthase Cause Clinically Important Echinocandin Resistance in Aspergillus fumigatus.
Satish S; Jiménez-Ortigosa C; Zhao Y; Lee MH; Dolgov E; Krüger T; Park S; Denning DW; Kniemeyer O; Brakhage AA; Perlin DS
mBio; 2019 Jun; 10(3):. PubMed ID: 31164462
[No Abstract] [Full Text] [Related]
84. Specific substitutions in the echinocandin target Fks1p account for reduced susceptibility of rare laboratory and clinical Candida sp. isolates.
Park S; Kelly R; Kahn JN; Robles J; Hsu MJ; Register E; Li W; Vyas V; Fan H; Abruzzo G; Flattery A; Gill C; Chrebet G; Parent SA; Kurtz M; Teppler H; Douglas CM; Perlin DS
Antimicrob Agents Chemother; 2005 Aug; 49(8):3264-73. PubMed ID: 16048935
[TBL] [Abstract][Full Text] [Related]
85. Genetic Analysis of
Kim SH; Iyer KR; Pardeshi L; Muñoz JF; Robbins N; Cuomo CA; Wong KH; Cowen LE
mBio; 2019 Jan; 10(1):. PubMed ID: 30696744
[No Abstract] [Full Text] [Related]
86. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
[TBL] [Abstract][Full Text] [Related]
87. Highly Dynamic and Specific Phosphatidylinositol 4,5-Bisphosphate, Septin, and Cell Wall Integrity Pathway Responses Correlate with Caspofungin Activity against Candida albicans.
Badrane H; Nguyen MH; Clancy CJ
Antimicrob Agents Chemother; 2016 Jun; 60(6):3591-600. PubMed ID: 27021331
[TBL] [Abstract][Full Text] [Related]
88. Assessing resistance to the echinocandin antifungal drug caspofungin in Candida albicans by profiling mutations in FKS1.
Balashov SV; Park S; Perlin DS
Antimicrob Agents Chemother; 2006 Jun; 50(6):2058-63. PubMed ID: 16723566
[TBL] [Abstract][Full Text] [Related]
89. Echinocandin antifungal drugs in fungal infections: a comparison.
Chen SC; Slavin MA; Sorrell TC
Drugs; 2011 Jan; 71(1):11-41. PubMed ID: 21175238
[TBL] [Abstract][Full Text] [Related]
90. Impact of the unfolded protein response upon genome-wide expression patterns, and the role of Hac1 in the polarized growth, of Candida albicans.
Wimalasena TT; Enjalbert B; Guillemette T; Plumridge A; Budge S; Yin Z; Brown AJ; Archer DB
Fungal Genet Biol; 2008 Sep; 45(9):1235-47. PubMed ID: 18602013
[TBL] [Abstract][Full Text] [Related]
91. All about CDR transporters: Past, present, and future.
Prasad R; Balzi E; Banerjee A; Khandelwal NK
Yeast; 2019 Apr; 36(4):223-233. PubMed ID: 30192990
[TBL] [Abstract][Full Text] [Related]
92. Rapid redistribution of phosphatidylinositol-(4,5)-bisphosphate and septins during the Candida albicans response to caspofungin.
Badrane H; Nguyen MH; Blankenship JR; Cheng S; Hao B; Mitchell AP; Clancy CJ
Antimicrob Agents Chemother; 2012 Sep; 56(9):4614-24. PubMed ID: 22687514
[TBL] [Abstract][Full Text] [Related]
93. Understanding Echinocandin Resistance in the Emerging Pathogen Candida auris.
Kordalewska M; Lee A; Park S; Berrio I; Chowdhary A; Zhao Y; Perlin DS
Antimicrob Agents Chemother; 2018 Jun; 62(6):. PubMed ID: 29632013
[No Abstract] [Full Text] [Related]
94. Genetic and genomic architecture of the evolution of resistance to antifungal drug combinations.
Hill JA; Ammar R; Torti D; Nislow C; Cowen LE
PLoS Genet; 2013 Apr; 9(4):e1003390. PubMed ID: 23593013
[TBL] [Abstract][Full Text] [Related]
95. Relevance of antifungal penetration in biofilm-associated resistance of Candida albicans and non-albicans Candida species.
Singh R; Kumari A; Kaur K; Sethi P; Chakrabarti A
J Med Microbiol; 2018 Jul; 67(7):922-926. PubMed ID: 29767615
[TBL] [Abstract][Full Text] [Related]
96. Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.
Cocuaud C; Rodier MH; Daniault G; Imbert C
J Antimicrob Chemother; 2005 Sep; 56(3):507-12. PubMed ID: 16040622
[TBL] [Abstract][Full Text] [Related]
97.
Suwunnakorn S; Wakabayashi H; Kordalewska M; Perlin DS; Rustchenko E
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29358288
[No Abstract] [Full Text] [Related]
98. Overcoming Fungal Echinocandin Resistance through Inhibition of the Non-essential Stress Kinase Yck2.
Caplan T; Lorente-Macías Á; Stogios PJ; Evdokimova E; Hyde S; Wellington MA; Liston S; Iyer KR; Puumala E; Shekhar-Guturja T; Robbins N; Savchenko A; Krysan DJ; Whitesell L; Zuercher WJ; Cowen LE
Cell Chem Biol; 2020 Mar; 27(3):269-282.e5. PubMed ID: 31924499
[TBL] [Abstract][Full Text] [Related]
99. An expanded cell wall damage signaling network is comprised of the transcription factors Rlm1 and Sko1 in Candida albicans.
Heredia MY; Ikeh MAC; Gunasekaran D; Conrad KA; Filimonava S; Marotta DH; Nobile CJ; Rauceo JM
PLoS Genet; 2020 Jul; 16(7):e1008908. PubMed ID: 32639995
[TBL] [Abstract][Full Text] [Related]
100. Caspofungin dose escalation for invasive candidiasis due to resistant Candida albicans.
Wiederhold NP; Najvar LK; Bocanegra RA; Kirkpatrick WR; Patterson TF
Antimicrob Agents Chemother; 2011 Jul; 55(7):3254-60. PubMed ID: 21502632
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
